Łukasz Wołowiec

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Pulmonary Hypertension

Ejection Fraction

Cardiovascular Disease

Top Venues

Annals of medicine

Molecules (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Kazimierz Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. Annals of medicine 56 (1) (2024)
Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Kazimierz Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. Annals of medicine 56 (1) (2024)
Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Kazimierz Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. Annals of medicine 56 (1) (2024)
Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Kazimierz Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. Annals of medicine 56 (1) (2024)
Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Kazimierz Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. Annals of medicine 56 (1) (2024)
Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Kazimierz Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. Annals of medicine 56 (1) (2024)
Grzegorz Grześk, Adrianna Witczyńska, Magdalena Węglarz, Łukasz Wołowiec, Jacek Nowaczyk, Elżbieta Grześk, Alicja Nowaczyk
Soluble Guanylyl Cyclase Activators-Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension. Molecules (Basel, Switzerland) 28 (2) (2023)
Grzegorz Grześk, Adrianna Witczyńska, Magdalena Węglarz, Łukasz Wołowiec, Jacek Nowaczyk, Elżbieta Grześk, Alicja Nowaczyk
Soluble Guanylyl Cyclase Activators-Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension. Molecules (Basel, Switzerland) 28 (2) (2023)
Grzegorz Grześk, Adrianna Witczyńska, Magdalena Węglarz, Łukasz Wołowiec, Jacek Nowaczyk, Elżbieta Grześk, Alicja Nowaczyk
Soluble Guanylyl Cyclase Activators-Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension. Molecules (Basel, Switzerland) 28 (2) (2023)
Łukasz Wołowiec, Mateusz Kusiak, Jacek Budzyński, Anna Wołowiec, Albert Jaśniak, Michał Wiciński, Agnieszka Pedrycz-Wieczorska, Daniel Rogowicz, Grzegorz Grześk
Therapeutic Drug Monitoring of Direct Oral Anticoagulants in Patients with Extremely Low and High Body Weight-Pilot Study. Journal of clinical medicine 12 (15) (2023)
Łukasz Wołowiec, Joanna Osiak, Anna Wołowiec, Aleksandra Wijata, Elżbieta Grześk, Mariusz Kozakiewicz, Joanna Banach, Alicja Nowaczyk, Jacek Nowaczyk, Grzegorz Grześk
Inclisiran-Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9. Pharmaceutics 15 (2) (2023)
Łukasz Wołowiec, Joanna Osiak, Anna Wołowiec, Aleksandra Wijata, Elżbieta Grześk, Mariusz Kozakiewicz, Joanna Banach, Alicja Nowaczyk, Jacek Nowaczyk, Grzegorz Grześk
Inclisiran-Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9. Pharmaceutics 15 (2) (2023)
Łukasz Wołowiec, Joanna Osiak, Anna Wołowiec, Aleksandra Wijata, Elżbieta Grześk, Mariusz Kozakiewicz, Joanna Banach, Alicja Nowaczyk, Jacek Nowaczyk, Grzegorz Grześk
Inclisiran-Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9. Pharmaceutics 15 (2) (2023)
Łukasz Wołowiec, Martyna Mędlewska, Joanna Osiak, Anna Wołowiec, Elżbieta Grześk, Albert Jaśniak, Grzegorz Grześk
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment. International journal of molecular sciences 24 (11) (2023)
Łukasz Wołowiec, Joanna Osiak, Anna Wołowiec, Aleksandra Wijata, Elżbieta Grześk, Mariusz Kozakiewicz, Joanna Banach, Alicja Nowaczyk, Jacek Nowaczyk, Grzegorz Grześk
Inclisiran-Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9. Pharmaceutics 15 (2) (2023)
Grzegorz Grześk, Adrianna Witczyńska, Magdalena Węglarz, Łukasz Wołowiec, Jacek Nowaczyk, Elżbieta Grześk, Alicja Nowaczyk
Soluble Guanylyl Cyclase Activators-Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension. Molecules (Basel, Switzerland) 28 (2) (2023)
Małgorzata Chudzińska, Łukasz Wołowiec, Joanna Banach, Daniel Rogowicz, Grzegorz Grześk
Alcohol and Cardiovascular Diseases-Do the Consumption Pattern and Dose Make the Difference? Journal of cardiovascular development and disease 9 (10) (2022)
Grzegorz Grześk, Daniel Rogowicz, Łukasz Wołowiec, Agnieszka Ratajczak, Wojciech Gilewski, Małgorzata Chudzińska, Anna Sinkiewicz, Joanna Banach
The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants. International journal of molecular sciences 22 (16) (2021)
Łukasz Wołowiec, Daniel Rogowicz, Joanna Banach, Wojciech Gilewski, Władysław Sinkiewicz, Grzegorz Grześk
Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up. Disease markers 2020 (2020)